Showing posts with label medication. Show all posts
Showing posts with label medication. Show all posts

Wednesday, October 29, 2008

FDA education program for over-the-counter medications

The US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER), in cooperation with the National Council on Patient Information and Education (NCPIE) and Maryland's Montgomery County Public Schools, has launched "Medicines in My Home," an interactive educational program about the safe and effective use of over-the-counter medicines, located at www.fda.gov/medsinmyhome. The website includes a "Teachers Room," featuring a PowerPoint presentation, pre- and post test, in class lesson materials, and materials and activities for use in the home with family members. Key concepts students will learn from the program are:

  1. The Drug Facts label tells you what a medicine treats, if it is right for you and your problem, and how to use the medicine;
  2. Read the label and follow the directions carefully and correctly;
  3. Two medicines with the same active ingredient shouldn't be used at the same time; and,
  4. Measure medicines correctly with measuring tools made for medicines.
The program emphasizes that medicines should be used only with permission from an adult and that if there are questions about medicine use, ask a pharmacist or doctor. Materials are provided to encourage students to share what they learn with their families so that all family members can learn to use over-the-counter medicines more safely.

Friday, July 18, 2008

Consumer Health Tip Sheets

The US Agency for Healthcare Research and Quality (AHRQ) offers many consumer health resources, including:

20 Tips to Help Prevent Medical Errors
Patient Fact Sheet
http://www.ahrq.gov/consumer/20tips.htm

20 Tips to Help Prevent Medical Errors in Children
Patient Fact Sheet
http://www.ahrq.gov/consumer/20tipkid.htm

Quick Tips—When Getting Medical Tests
http://www.ahrq.gov/consumer/quicktips/tiptests.htm

Quick Tips—When Talking with Your Doctor
http://www.ahrq.gov/consumer/quicktips/doctalk.htm

Friday, March 28, 2008

Patient education video and audio information

The US Agency for Healthcare Research and Quality (AHRQ) provides a wealth of practical patient information. Especially helpful are video and audio files from AHRQ's Healthology website and Healthcare 411 series.

From Healthology:
Tips for Taking Medicines Safely (video; 5 minutes)

Next Steps After a Diagnosis (video; 8 minutes)

From Healthcare 411:
How to Ask Tough Questions of Your Doctor (audio; nearly 4 minutes)

Family Health Advocacy (audio; 10 minutes)

Monday, March 03, 2008

How to Create a Pill Card

How to Create a Pill Card is available at the AHRQ (Agency for Healthcare Research and Quality) website.

"This guide was designed to help users create an easy-to-use 'pill card' for patients, parents, or anyone who has a hard time keeping track of their medicines. Step-by-step instructions, sample clip art, and suggestions for design and use will help to customize a reminder card."

Contents

  • How to Create a Pill Card
  • Why Create a Pill Card?
  • What You Will Need to Create a Pill Card
  • Getting Ready to Create a Personalized Pill Card
  • Creating a Personalized Pill Card
  • Using a Personalized Pill Card
  • Pill Card Template
  • Common Pill Shapes
  • Common Images for Medication Uses
  • Acknowledgment and Disclaimer
http://www.ahrq.gov/qual/pillcard/pillcard.htm

Friday, September 28, 2007

Halifax pharmacy researcher explores medication errors in Canada

It’s the fourth leading cause of death among North Americans and costs billions of dollars each year in unnecessary health expenses, just for Canadian seniors alone. A Dalhousie University researcher is tackling the widespread issue of medication errors, and his efforts have landed him a prestigious international opportunity.

Dr. Neil J. MacKinnon has been selected as a 2007 Harkness Associate, a fellowship administered by the U.S. Commonwealth Fund and the Canadian Health Services Research Foundation. The Harkness program is limited to 13 individuals worldwide each year, including a maximum of two Canadians.

Dr. MacKinnon will embark on a major study to determine whether government and private payer drug policies improve safety and quality or unintentionally contribute to the problem of medication mistakes.

“There are obviously many benefits to medication, which can often replace surgery or greatly improve a patient’s quality of life,” says Dr. MacKinnon, associate director for research and associate professor at Dalhousie’s College of Pharmacy.

But the health care system is so complex, there are inevitably gaps in the process, he adds. These might include an incorrect diagnosis, insufficient lab work or a lack of patient monitoring. Surprisingly, a major barrier to proper medication in Canada is access – many people can’t afford it, and end up splitting tablets and reducing dosages without informing their doctors or pharmacists. Resulting problems from medication errors, such as adverse drug reactions, are the fourth-leading cause of death in Canada and the U.S.

One of his main research efforts is an examination of the many points of transfer in patient care. When patients are admitted to a nursing home or discharged from a hospital, a number of people and steps are involved in the transfer of their medications: nurses, physicians, order clerks, pharmacists, pharmacy technicians, the patients and their family doctors.

“The biggest red flags are those transition points,” says Dr. MacKinnon. “There could be 15 or more different handoffs between when the medication order is written by the physician and the time the patient actually puts the first pill in his or her mouth.”

He cites his 2005 study that found discrepancies in one out of every 11 medication orders at a Halifax hospital. In another one of his studies, one patient with multiple medication errors had 46 unnecessary emergency room visits in a nine-month period. In yet another of his studies, 519 seniors with thyroid conditions were taking their prescriptions properly, but weren’t having lab work done to monitor their thyroid levels, and ended up in emergency rooms or were hospitalized as a result.

“A lot of the solutions aren’t horribly complicated; it’s simply a matter of a phone call or a fax, and better communication,” says Dr. MacKinnon. He outlines a number of useful strategies for front-line health care professionals and scholars in a new book he edited, Safe and Effective: The Eight Essential Elements of an Optimal Medication-Use System, released last month in Ottawa.

Dr. MacKinnon teaches at Dalhousie, where he is a faculty member in the College of Pharmacy, the Faculty of Medicine’s Department of Community Health & Epidemiology, and the School of Health Services Administration.

Wednesday, September 12, 2007

Prescription labels geared toward pharmacies, not patients

The labels on most prescription drug containers highlight the pharmacy’s name or logo rather than instructions on how to take the medication, reports a new study in the September 10th issue of the Archives of Internal Medicine.

In the US, the Food and Drug Administration has some standards on what prescription labels must include, but few regulations guide the format of the information, said lead author William Shrank, M.D., of Brigham and Women’s Hospital at Harvard Medical School.

In the study, six pharmacies in four cities filled identically written prescriptions for four commonly prescribed medications. The pharmacies included the two largest chains, two grocery stores and two independent pharmacies.

Researchers evaluated 85 labels. They found the pharmacy name or logo was the most prominent item on 84 percent of the labels, with an average 13.6-point font size. By comparison, the instructions averaged a 9.3-point size and medication names averaged an 8.9-point font. Warning stickers were in a much smaller, 6.5-point font on average.

“Medical education guidelines explicitly suggest that font size must be 12 point or larger to optimize patients’ ability to read health information,” according to the authors.

All of the labels listed the pharmacy name first, and instructions appeared fifth on 89 percent of labels. When color font or boldface was present, it was most often for pharmacy information rather than for instructions or warnings.

The authors suggest that one way to improve readability and patient understanding of labels is for FDA to initiate a national standard for their format and content—much like it did with the “Nutrition Facts” labels required on food packaging.

Jennifer Athay, a staff pharmacist with the American Pharmacists Association, said, "Logistically, there is no way to get all the information someone needs to know on a little prescription bottle or tube. Size tends to be an issue, so the complete information you need to know is dispensed in the extra paperwork you get from the pharmacists.” She added that patients should ideally get detailed information when physicians first prescribe the medication to them.

Reference:
Shrank WH, et al. The variability and quality of medication container labels. Arch Intern Med 167(16), 2007

Thursday, July 05, 2007

Bipolar Disorder: A review of Medication & Self-management Strategies

TIME SENSITIVE

Bipolar Disorder: A review of Medication & Self-management Strategies is an education night for consumers and their families

July 10th, 2007
7:00 - 9:00 pm
UBC Robson Square Theatre
800 Robson Street
Vancouver, BC

Pre-registration required (seating limited)
Cost: $5.00 (waived in cases of financial hardship)

Contact:
Heather Armstrong
UBC Mood Disorders Centre
Room 2C7-2255 Wesbrook Mall
Vancouver, BC V6T 2A1
phone 604-822-8045
email hla@interchange.ubc.ca

A flyer with speakers and topics is available.

Tuesday, July 03, 2007

"Shared Voices" MS Society Newsletter great source of tips

Shared Voices is an excellent newsletter published by the MS Society of Canada's Lower Mainland chapter. The Summer 2007 issue is packed with terrific information for people living with MS—much of it of interest to people with other types of disabilities or health conditions as well. Copies are available at the website. Check out this issue for the following items and more:

  • tips for keeping cool during the summer heat (p. 1-2)
  • a report on a Nordic Pole Walking Workshop at the WestEnd MS Support Group (p.3)
  • Lower Mainland Chapter educational workshop September 22nd 2007 (p. 4)
  • A Light-hearted Parody of Your Summer Horoscope (p. 6-7)
  • information about accessible pools, beaches, and musical events in the Lower Mainland
  • Massage and more ... information about the West Coast College of Massage Therapy's Inreach Program for people living with MS. Over a 14-week term, massage therapy students provide weekly 60 minute massages (under supervision). "Besides the many benefits of massage, a mini support group usually develops. Some have found their fear of becoming less mobile lessens when they see those who use various aids—canes, walkers, wheelchairs and scooters—living successfully." (p. 5)
  • Therapeutic and Research Issues: Mitoxantrone (might-oh-zan-trone) (p. 4)
Note: The West Coast College of Massage Therapy is located in New Westminster. Each massage is $10.00. The program is currently full, but if you're interested, call Brenda at 604-451-8616 to be placed on a cancellation list.

Wednesday, June 20, 2007

Drug information too hard to read and understand

To make drug information easier to read, researchers recommend:
• using short, familiar words and short sentences
• using short headings that stand out
• using the largest possible type size
• leaving plenty of white space
• using bullet points to organize lists.

Earlier this year, researchers announced the results of a systematic review of studies examining the usefulness to patients of medication information sheets. The review covered the United Kingdom, Europe, Australia and the United States and found that information does not meet the needs of patients. Poor layout and complex language often hinder communication.

The reviewers emphasize that patients want written information in addition to—not instead of—spoken instructions from their health care professionals. Many people would like information that better helps them evaluate potential benefits and harms of a drug treatment. Lead author D.K. Raynor, Ph.D., of the University of Leeds in England says that one key finding was an apparent dichotomy between prescriber and patient views of the fundamental purpose of drug leaflets.

Some providers see increasing treatment compliance as a primary function. In contrast, patients say an informed decision not to take a medicine is also an acceptable result. “Patients see the role of written medical information as guiding them in terms of which medicine is right for them and, if they take the medicine, how best they can use it,” Raynor said. To that end, patients would also like to see more balance between benefit and harm information.

Current drug information focuses too heavily on warnings and adverse effects of the medication, Raynor said. “Patients also need to know how it might benefit them and how likely it is to benefit them.” Exactly how to convey the likelihood of benefits and harms most clearly remains in question. Verbal descriptors like “rare” or “common” are too vague, according to the review.

Yet, more scientific terminology like percentages or “numbers needed to treat” can also confuse the lay public. More research is needed in how best to communicate probability data to consumers, the reviewers say.

To read the full report:
Raynor DK, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technology Assessment 11(5), 2007.